Real-life efficacy and safety of biologic treatment in patients with moderate to severe psoriasis and previous diagnosis of a malignant tumor: Single-center descriptive study

被引：0
|
作者：
Duran Romero, Antonio Jose [1 ]
Fernandez Freire, Lourdes Rodriguez [1 ]
Sendin Martin, Mercedes [1 ]
Ortiz Alvarez, Juan [1 ]
Hernandez Rodriguez, Juan Carlos [1 ]
Conejo-Mir Sanchez, Julian [1 ]
机构：
[1] Univ Hosp Virgen Rocio, Dermatol Dept, Seville, Spain
来源：
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY | 2022年 / 87卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
34115
引用
下载
收藏
页码：AB198 / AB198
页数：1
相关论文
共 50 条
  • [1] Single-Center Real-Life Experience of Guselkumab in Patients with Moderate-to-Severe Plaque Psoriasis
    Marletta, Dario
    Murgia, Giulia
    Cattaneo, Angelo
    Carrera, Carlo
    Marzano, Angelo
    JOURNAL OF DRUGS IN DERMATOLOGY, 2022, 21 (08) : 864 - 866
  • [2] Tildrakizumab for the treatment of moderate to severe psoriasis: Results from a single center preliminary real-life study
    Ruggiero, Angelo
    Potestio, Luca
    Cacciapuoti, Sara
    Gallo, Lucia
    Battista, Teresa
    Camela, Elisa
    Fabbrocini, Gabriella
    Megna, Matteo
    DERMATOLOGIC THERAPY, 2022, 35 (12)
  • [3] Biologic therapies for plaque type psoriasis in patients with previous malignant cancer: long-term safety in a single- center real-life population
    Valenti, M.
    Pavia, G.
    Gargiulo, L.
    Facheris, P.
    Sanna, F.
    Borroni, R. G.
    Costanzo, A.
    Narcisi, A.
    JOURNAL OF DERMATOLOGICAL TREATMENT, 2022, 33 (03) : 1638 - 1642
  • [4] Efficacy and safety of secukinumab in Chinese patients with moderate-to-severe plaque psoriasis: a real-life cohort study
    Zhao, Yan
    Cai, Lin
    Liu, Xiao-Yang
    Zhang, Heng
    Zhang, Jian-Zhong
    CHINESE MEDICAL JOURNAL, 2021, 134 (11) : 1324 - 1328
  • [5] PSSD and Biologic Therapy: Real-Life Data in 417 Patients with Moderate to Severe Psoriasis
    Proietti, Ilaria
    Bernardini, Nicoletta
    Skroza, Nevena
    Mambrin, Alessandra
    Tolino, Ersilia
    Marchesiello, Anna
    Marraffa, Federica
    Rossi, Giovanni
    Volpe, Salvatore
    Potenza, Concetta
    REVIEWS ON RECENT CLINICAL TRIALS, 2022, 17 (03) : 171 - 176
  • [6] Ixekizumab and brodalumab indirect comparison in the treatment of moderate to severe psoriasis: Results from an Italian single-center retrospective study in a real-life setting
    Megna, Matteo
    Potestio, Luca
    Camela, Elisa
    Fabbrocini, Gabriella
    Ruggiero, Angelo
    DERMATOLOGIC THERAPY, 2022, 35 (09)
  • [7] Tildrakizumab in real-life shows good efficacy in moderate-to-severe psoriasis regardless of previous use of biologic drugs and joint involvement
    Mastorino, Luca
    Cariti, Caterina
    Susca, Sara
    Sciamarrelli, Nadia
    Borriello, Silvia
    Ortoncelli, Michela
    Stroppiana, Elena
    Verrone, Anna
    Dapavo, Paolo
    Quaglino, Pietro
    Ribero, Simone
    DERMATOLOGIC THERAPY, 2022, 35 (11)
  • [8] Effectiveness and safety of secukinumab in patients with moderate-severe psoriasis: A multicenter real-life study
    Carpentieri, Antonio
    Mascia, Paola
    Fornaro, Marco
    Beylot-Barry, Marie
    Taieb, Alain
    Foti, Caterina
    Loconsole, Francesco
    DERMATOLOGIC THERAPY, 2020, 33 (06)
  • [9] REAL-LIFE EFFICACY AND SAFETY OF IXEKIZUMAB IN A COHORT OF PATIENTS WITH PSORIATIC ARTHRITIS: A SINGLE-CENTER RETROSPECTIVE STUDY
    Bellis, E.
    Donzella, D.
    Crepaldi, G.
    Data, V.
    Gammino, M.
    Guardo, V.
    Lomater, C.
    Marucco, E.
    Saracco, M.
    Iagnocco, A.
    ANNALS OF THE RHEUMATIC DISEASES, 2023, 82 : 1790 - 1790
  • [10] The real-life efficacy and safety of secukinumab therapy (150 and 300 mg) in patients with moderate-to-severe plaque psoriasis: A twelve week, single center, retrospective study
    Yildizhan, Incilay Kalay
    Aygun, Merve
    Kundakci, Nihal
    TURKDERM-TURKISH ARCHIVES OF DERMATOLOGY AND VENEROLOGY, 2021, 55 (03): : 113 - 118
12345